A cost variation analysis of the antihypertensives:  The essential of medicines list to fit the bill

Background: Fluoroquinolone eye drops is being prescribed by Opthalmologist in many ocular diseases as conjunctivitis, keratitis, bacterial corneal ulcers etc in more and more amount. There are many brands of fluoroquinolones drugs available in Indian market. Costly drugs can lead to economic burden on patients. Modifications in pharmaceutical policy are required, and prices of the drug should be controlled in effective way for all the drugs. Hence this study was done to assess the cost variation of fluoroquinolones opthalmic solutions available in Indian market.Methods: The maximum and minimum price of each brand of the drug in INR was noted by using CIMS January to April 2020 edition and Drug Today April to June 2020 volume 1. The cost ratio and the percentage cost variation for individual drug brands was calculated. The cost of each eye drop was calculated. At last the cost ratio and percentage cost variation of various brands was compared.Results: Percentage variation in cost for fluoroquinolones eye preparations marketed in India was found to be Eye drop Ciprofloxacin (0.3%) of 5 ml:210.39, Eye drop Ciprofloxacin (0.3%) of 10 ml:162, Eye drop Gatifloxacin (0.3%) of 5 ml:156, Eye drop Moxifloxacin (0.5%) of 5 ml:196.95, Eye drop Ofloxacin (0.3%) of 5 ml:245.16, Eye drop Ofloxacin (0.3%) of 10 ml:62.5, Eye drop Norfloxacin (0.3%) of 5 ml:120.68, Eye drop Sparfloxacin (0.3%):8.31, Eye drop Lomefloxacin (0.3%):16.17.Conclusions: There is a wide difference in the cost of different brands of fluoroquinolones eye preparations available in India. The clinicians prescribing these drugs should be aware of these variations in cost to reduce the cost of drug therapy.

Download Full-text

Study of the cost variation analysis of anti-epileptic drugs available in different brands in Indian pharmaceutical market

International Journal of Basic & Clinical Pharmacology ◽

10.18203/2319-2003.ijbcp20211647 ◽

2021 ◽

Vol 10 (5) ◽

pp. 523

Author(s):

Hansraj Kumar ◽

Uma Shankar Prasad Kesari ◽

Rajiv Kumar

Keyword(s):

Drug Therapy ◽

Neurological Disorder ◽

Cost Ratio ◽

Variation Analysis ◽

Oral Drugs ◽

Injectable Drugs ◽

Cost Variation ◽

Anti Epileptic Drug ◽

Minimum Price ◽

The Cost

Background: The aim of this study was to analyze the cost ratio and percentage cost variations in different brands of the commonly prescribed anti-epileptic drugs available in Indian pharmaceutical market.Methods: The maximum and minimum price of each brand of the drug given in Indian rupees (INR) was noted by using CIMS January to April 2020 edition and drug today April to June 2020 volume 1. The cost ratio and the percentage cost variation for individual drug brands was calculated. The cost of one bottle in case of 100 ml syrup and 10 tablets/capsules was calculated in case of oral drugs and the cost of one 1 vial or ampoule was noted in case of injectable drugs. At last the cost ratio and percentage cost variation of various brands was compared.Results: After calculation of cost ratio and percentage cost variation for each brand of anti-epileptic drug tablet clonazepam (2 mg) shows highest cost ratio and percentage cost variation as 10.41 and 941.66, carbamazepine (200 mg SR tablet) shows lowest cost ratio and percentage cost variation as 1.09 and 9.32.Conclusions: Epilepsy is the most common neurological disorder and epileptic drugs are to be prescribed for prolonged period. If a costly brand is prescribed, the patients have to pay more money unnecessarily for their treatment. There is a wide difference in the cost of different brands of anti-epileptic drugs available in India. The clinicians prescribing these drugs should be aware of these variations in cost to reduce the cost of drug therapy.

Download Full-text

Pharmacoeco-economic study: A cost variation analysis of AKT drugs available in Indian market

Indian Journal of Pharmacy and Pharmacology ◽

10.18231/2393-9087.2019.0002 ◽

2019 ◽

Vol 6 (1) ◽

pp. 6-10

Author(s):

Jitendra R. Zaveri ◽

◽

Archanabahen Archanabahen ◽

Keyword(s):

Variation Analysis ◽

Indian Market ◽

Economic Study ◽

Cost Variation

Download Full-text

Pharmaco-economics Study: A cost variation analysis of various statin preparations available in Nepali market

Nepal Mediciti Medical Journal ◽

10.3126/nmmj.v1i1.34470 ◽

2020 ◽

Vol 1 (1) ◽

pp. 14-16

Author(s):

Sirisa Karki ◽

Gita Paudel ◽

Karma Murti Bhurtyal

Keyword(s):

Low Cost ◽

Drug Prescription ◽

Cost Ratio ◽

Market Regulation ◽

Variation Analysis ◽

Cost Variation ◽

National Priority ◽

Rational Drug ◽

Proven Efficacy ◽

Indian Product

Background: Hyperlipidemia is one of the greatest risk factors contributing to prevalence and severity of cardiovascular diseases. Treatment of hyperlipidemia with statins have proven efficacy in reduction of cardiovascular events. In the present study, we aim to find out the variation in cost of commercially available statin products in Nepal. Methods: The price of different statin products with same formulation and strength was obtained from various medicine importers and distributors inside Kathmandu valley, Pokhara and Chitwan. Percentage of cost variation and cost ratio was calculated. Results: High percentage of cost variation was observed among Indian product with Atorvastatin 10 mg (898.8% Cost ratio: 9.98) followed by Atorvastatin 20mg (894.52% Cost ratio: 9.94). Least percentage of cost variation was observed with Nepal manufactured Atorvastatin 5mg (49.62 Cost ratio: 1.49). Conclusion: There is a wide percentage of cost variation with available statins in the Nepali market. Regulation of drug price by concerned agencies and by government should be a national priority. Rational drug prescription with low cost is important for treatment adherence and disease outcome

Download Full-text